Relative survival is an adequate estimate of cancer-specific survival: Baseline mortality-adjusted 10-year survival of 771 rectal cancer patients

Annals of Surgical Oncology

Volumn 20, Issue 12, 2013, Pages 3877-3884

  Tarantino, Ignazio ^a   Achermann, Philipp ^a   Güller, Ulrich ^a,b   Ulrich, Alexis ^c   Schmied, Bruno M ^a   Horber, Daniel ^a   Cerny, Thomas ^a   Stanga, Zeno ^b   Warschkow, Rene ^a,c  

^a Kantonsspital St Gallen ^*  (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SPECIFIC SURVIVAL; CANCER STAGING; COHORT ANALYSIS; DEATH; FEMALE; FOLLOW UP; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RECTUM CANCER; RELATIVE SURVIVAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84886090449     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3173-5     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Colorectal cancer. Lancet. 2010;375:1030-47.
3. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730-56.
4. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377:127-38.
5. Therneau TM, Offord J. Expected survival based on hazard rates (update). Rochester, MN: Department of Health Science Research, Mayo Clinic; 1999. Technical Report Series No. 63.
6. Cutler SJ, Axtell LM, Schottenfeld D. Adjustment of long-term survival rates for deaths due to intercurrent disease. J Chronic Dis. 1969;22:485-91.
7. Ashworth TG. Inadequacy of death certification: proposal for change. J Clin Pathol. 1991;44:265-8.
8. Begg CB, Schrag D. Attribution of deaths following cancer treatment. J Natl Cancer Inst. 2002;94:1044-5.
9. Welch HG, Black WC. Are deaths within 1 month of cancer-directed surgery attributed to cancer? J Natl Cancer Inst. 2002;94:1066-70.
10. Warschkow R, Tarantino I, Torzewski M, Naf F, Lange J, Steffen T. Diagnostic accuracy of C-reactive protein and white blood cell counts in the early detection of inflammatory complications after open resection of colorectal cancer: a retrospective study of 1,187 patients. Int J Colorectal Dis. 2011;26:1405-13.
11. Warschkow R, Steffen T, Luthi A, et al. Epidural analgesia in open resection of colorectal cancer: is there a clinical benefit? a retrospective study on 1,470 patients. J Gastrointest Surg. 2011;15:1386-93.
12. Warschkow R, Steffen T, Thierbach J, Bruckner T, Lange J, Tarantino I. Risk factors for anastomotic leakage after rectal cancer resection and reconstruction with colorectostomy. A retrospective study with bootstrap analysis. Ann Surg Oncol. 2011;18:2772-82.
13. Tarantino I, Warschkow R, Worni M, et al. Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients. Br J Cancer. 2012;107:266-74.
14. Warschkow R, Guller U, Koberle D, et al. Perioperative blood transfusions do not impact overall and disease-free survival after curative rectal cancer resection: a propensity score analysis. Ann Surg 2013.
15. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-40.
16. Schweizerische Gesellschaft für Gastroenterologie. Konsensus-Empfehlungen zur Nachsorge nach kurativ operiertem kolorektalem Karzinom. Available at: http://www.sggssg.ch/uploads/media/NaSo-CRC-d.pdf. Accessed 7 Jul 2012.
17. Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol. 2010;39:598-610.
18. Schweizerische Eidgenossenschaft BfS. Jährliche Sterbetafeln. Available at: http://www.bfs.admin.ch/bfs/portal/de/index/themen/01/06/blank/ dos/la-mortalite-en-suisse/tabl02.html. Accessed 12 Jul 2012.
19. Pohar M, Stare J. Making relative survival analysis relatively easy. Comput Biol Med. 2007;37:1741-9.
20. Andersen PK, Borch-Johnsen K, Deckert T, et al. A Cox regression model for the relative mortality and its application to diabetes mellitus survival data. Biometrics. 1985;41:921-32.
21. Gamel JW, Vogel RL. Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients. Stat Methods Med Res. 2001;10:339-52.
22. James DS, Bull AD. Information on death certificates: cause for concern? J Clin Pathol. 1996;49:213-6.
23. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260:103-17.
24. Rachet B, Coleman MP. Estimating cancer survival - which is the right approach? [commentary]. Int J Epidemiol. 2010;39:611-2.
25. Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol. 2007;8:773-83.
26. Gondos A, Bray F, Brewster DH, et al. Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer. 2008;44:1463-75.
27. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44:1345-89.
28. Gobbi PG, Valentino F, Berardi E, et al. New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer. Br J Cancer. 2008;98:328-34.
29. Rutherford MJ, Dickman PW, Lambert PC. Comparison of methods for calculating relative survival in population-based studies. Cancer Epidemiol. 2012;36:16-21.
30. Nur U, Shack LG, Rachet B, Carpenter JR, Coleman MP. Modelling relative survival in the presence of incomplete data: a tutorial. Int J Epidemiol. 2010;39:118-28.
31. Horton NJ, Lipsitz SR. Multiple imputation in practice: comparison of software packages for regression models with missing variables. Am Stat. 2001;55:244-54.
32. Robinson D, Sankila R, Hakulinen T, Moller H. Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer. 2007;43:909-13.
33. Yu XQ, O'Connell DL, Gibberd RW, Abrahamowicz M, Armstrong BK. Misclassification of colorectal cancer stage and area variation in survival. Int J Cancer. 2008;122:398-402.
34. Kuntz KM, Weinstein MC. Life expectancy biases in clinical decision modeling. Med Decis Making. 1995;15:158-69.